Dianne Athene Ledesma (Dianne A Ledesma)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Systemic Sclerosis

Neuropathic Pain

Prognostic Factors

Ejection Fraction

Top Venues

Future oncology (London, England)

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Koichiro Akakura, Hiroji Uemura, Satoru Kawakami, Akira Yokomizo, Motonobu Nakamura, Kazuo Nishimura, Tetsushi Komori, Dianne Athene Ledesma
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan. Future oncology (London, England) 20 (12) (2024)
Koichiro Akakura, Hiroji Uemura, Satoru Kawakami, Akira Yokomizo, Motonobu Nakamura, Kazuo Nishimura, Tetsushi Komori, Dianne Athene Ledesma
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan. Future oncology (London, England) (2024)
Koichiro Akakura, Hiroji Uemura, Satoru Kawakami, Akira Yokomizo, Motonobu Nakamura, Kazuo Nishimura, Tetsushi Komori, Dianne Athene Ledesma
Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan. Future oncology (London, England) 20 (12) (2024)
Kazuo Nishimura, Masaki Shiota, Masatoshi Eto, Takefumi Satoh, Angela Stroupe, Caroline Seo, Alyssa Uzumcu, Dianne Athene Ledesma
Conceptual assessment of HRQOL among Japanese non-metastatic castration-resistant prostate cancer (nmCRPC) patients. Cancer medicine (2022)
Koichiro Akakura, Hiroji Uemura, Kikuko Miyazaki, Angela Stroupe, Caroline Seo, Alyssa Uzumcu, Dianne Athene Ledesma
A qualitative research study in Japan investigating patients' experience with metastatic castration-resistant prostate cancer: from diagnosis to decision for Ra-223 treatment. Future oncology (London, England) 17 (36) (2021)
Hiroji Uemura, Hisashi Matsushima, Akira Yokomizo, Kazuki Kobayashi, Gaku Arai, Takefumi Satoh, Vince Grillo, Yirong Chen, Shikha Singh, Dianne Athene Ledesma
Unmet needs in non-metastatic castration-resistant prostate cancer from the Japanese patient perspective: a discrete choice experiment. BMJ open 11 (8) (2021)